Cas no 20443-38-3 (5-Chloro-2-chloromethyl-1H-benzoimidazole)
5-Chloro-2-chloromethyl-1H-benzoimidazole Chemical and Physical Properties
Names and Identifiers
-
- 5-Chloro-2-(chloromethyl)-1H-benzo[d]imidazole
- 5-Chloro-2-(chloromethyl)-1H-benzimidazole
- 5-Chloro-2-chloromethyl-1H-benzoimidazole
- 6-chloro-2-(chloromethyl)-1H-Benzimidazole
- 5-Chlor-2-chlormethyl-1(3)H-benzimidazol
- 5-chloro-2-(chloromethyl)-1H-1,3-benzodiazole
- 5-chloro-2-chloromethyl-1(3)H-benzoimidazole
- 5-chloro-2-chloromethylbenzimidazole
- NSC-114752
- AB02394
- AS-8223
- DTXSID60297217
- 20443-38-3
- D81730
- SR-01000052939-1
- 1H-Benzimidazole, 6-chloro-2-(chloromethyl)-
- NSC114752
- A879617
- A814663
- L-5,5-DIMETHYLTHIAZOLIDINE-4-CARBOXYLICACID
- SR-01000052939
- SCHEMBL485294
- EN300-08873
- 5-Chloro-2-(chloromethyl)-1H-benzimidazole #
- 6-Chloro-2-(chloromethyl)-1H-benzo[d]imidazole
- 6-chloro-2-chloromethylbenzimidazole
- MFCD00060503
- 6-chloranyl-2-(chloromethyl)-1H-benzimidazole
- AKOS000302008
- FT-0677814
- ALBB-027325
- 1H-Benzimidazole, 5-chloro-2-(chloromethyl)-
- DB-014565
-
- MDL: MFCD00060503
- Inchi: 1S/C8H6Cl2N2/c9-4-8-11-6-2-1-5(10)3-7(6)12-8/h1-3H,4H2,(H,11,12)
- InChI Key: CJNALUZDTPETCS-UHFFFAOYSA-N
- SMILES: ClCC1=NC2C=CC(=CC=2N1)Cl
Computed Properties
- Exact Mass: 199.99100
- Monoisotopic Mass: 199.991
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 12
- Rotatable Bond Count: 1
- Complexity: 165
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- Tautomer Count: 2
- XLogP3: nothing
- Topological Polar Surface Area: 28.7A^2
Experimental Properties
- Density: 1.492
- Boiling Point: 404.6 °C at 760 mmHg
- Flash Point: 230.9 °C
- Refractive Index: 1.686
- PSA: 28.68000
- LogP: 2.95510
5-Chloro-2-chloromethyl-1H-benzoimidazole Customs Data
- HS CODE:2933990090
- Customs Data:
China Customs Code:
2933990090Overview:
2933990090. Other heterocyclic compounds containing only nitrogen heteroatoms. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
5-Chloro-2-chloromethyl-1H-benzoimidazole Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | 019831-500mg |
5-Chloro-2-chloromethyl-1H-benzoimidazole |
20443-38-3 | 500mg |
1331CNY | 2021-05-07 | ||
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | 019831-1g |
5-Chloro-2-chloromethyl-1H-benzoimidazole |
20443-38-3 | 1g |
2192CNY | 2021-05-07 | ||
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-KQ526-250mg |
5-Chloro-2-chloromethyl-1H-benzoimidazole |
20443-38-3 | 95+% | 250mg |
989CNY | 2021-05-07 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-KQ526-100mg |
5-Chloro-2-chloromethyl-1H-benzoimidazole |
20443-38-3 | 95+% | 100mg |
411CNY | 2021-05-07 | |
| Chemenu | CM155797-5g |
6-Chloro-2-(chloromethyl)-1H-benzo[d]imidazole |
20443-38-3 | 95% | 5g |
$626 | 2021-06-08 | |
| Fluorochem | 059873-1g |
5-Chloro-2-chloromethyl-1H-benzoimidazole |
20443-38-3 | 95% | 1g |
£96.00 | 2022-02-28 | |
| Fluorochem | 059873-250mg |
5-Chloro-2-chloromethyl-1H-benzoimidazole |
20443-38-3 | 95% | 250mg |
£44.00 | 2022-02-28 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | 019831-500mg |
5-Chloro-2-chloromethyl-1H-benzoimidazole |
20443-38-3 | 500mg |
1331.0CNY | 2021-07-13 | ||
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | 019831-1g |
5-Chloro-2-chloromethyl-1H-benzoimidazole |
20443-38-3 | 1g |
2192.0CNY | 2021-07-13 | ||
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-KQ526-50mg |
5-Chloro-2-chloromethyl-1H-benzoimidazole |
20443-38-3 | 95+% | 50mg |
247.0CNY | 2021-07-13 |
5-Chloro-2-chloromethyl-1H-benzoimidazole Related Literature
-
Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480
-
Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
-
Xingjie Wu,Linzhu Zhou,Yue Su,Chang-Ming Dong J. Mater. Chem. B, 2016,4, 2142-2152
-
Tong Xu,Dongwei Ma,Chengbo Li,Qian Liu,Siyu Lu,Abdullah M. Asiri,Chun Yang,Xuping Sun Chem. Commun., 2020,56, 3673-3676
-
Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
Additional information on 5-Chloro-2-chloromethyl-1H-benzoimidazole
Professional Introduction to 5-Chloro-2-chloromethyl-1H-benzoimidazole (CAS No. 20443-38-3)
5-Chloro-2-chloromethyl-1H-benzoimidazole (CAS No. 20443-38-3) is a versatile heterocyclic compound that has garnered significant attention in the field of pharmaceutical and chemical research due to its unique structural properties and potential biological activities. This compound, featuring a benzoimidazole core with chloro and chloromethyl substituents, presents an intriguing scaffold for the development of novel therapeutic agents.
The benzoimidazole moiety is a well-documented pharmacophore in medicinal chemistry, known for its role in various bioactive molecules. The presence of chlorine atoms at the 5-position and 2-position enhances the electrophilicity of the molecule, making it a valuable intermediate for further functionalization. Specifically, the chloromethyl group at the 2-position offers a reactive site for nucleophilic substitution reactions, enabling the synthesis of more complex derivatives.
In recent years, 5-Chloro-2-chloromethyl-1H-benzoimidazole has been explored in several research studies for its potential applications in drug discovery. One notable area of interest is its role as a precursor in the synthesis of antiviral and anticancer agents. The benzoimidazole scaffold is structurally similar to several known bioactive compounds, suggesting that derivatives of this molecule may exhibit comparable pharmacological effects.
A particularly compelling aspect of this compound is its reactivity with nucleophiles, which allows for the introduction of diverse functional groups. This flexibility has been leveraged in the development of 5-Chloro-2-chloromethyl-1H-benzoimidazole based inhibitors targeting specific enzymatic pathways involved in diseases such as cancer and inflammation. For instance, researchers have utilized this compound to generate inhibitors of kinases and other enzymes implicated in tumor growth and progression.
Recent advancements in synthetic methodologies have further enhanced the utility of 5-Chloro-2-chloromethyl-1H-benzoimidazole as a building block. Techniques such as palladium-catalyzed cross-coupling reactions have enabled the efficient introduction of aryl or heteroaryl groups at various positions on the benzoimidazole ring. This has opened up new avenues for creating structurally diverse derivatives with tailored biological properties.
The chloro substituents on the benzoimidazole ring also contribute to the compound's reactivity, allowing for further modifications through halogen-metal exchange or metal-halogen exchange reactions. These transformations have been instrumental in generating novel analogs with enhanced solubility or improved metabolic stability, critical factors for drug development.
In addition to its applications in pharmaceutical research, 5-Chloro-2-chloromethyl-1H-benzoimidazole has shown promise in materials science. Its ability to undergo polymerization or copolymerization with other monomers has led to the development of novel polymeric materials with unique properties. These materials have potential applications in coatings, adhesives, and even biodegradable polymers.
The synthesis of 5-Chloro-2-chloromethyl-1H-benzoimidazole itself is a testament to modern organic chemistry techniques. While traditional methods involving chlorination and methylation reactions are still prevalent, newer approaches employing flow chemistry or microwave-assisted synthesis have improved yields and reduced reaction times. These innovations not only make the production of this compound more efficient but also more environmentally friendly.
As research continues to uncover new applications for 5-Chloro-2-chloromethyl-1H-benzoimidazole, its importance in both academic and industrial settings is likely to grow. The compound's versatility as a synthetic intermediate and its potential biological activity make it a cornerstone of modern drug discovery efforts. Furthermore, its role in developing advanced materials underscores its broader impact on science and technology.
In conclusion, 5-Chloro-2-chloromethyl-1H-benzoimidazole (CAS No. 20443-38-3) represents a fascinating compound with far-reaching implications across multiple scientific disciplines. Its unique structural features and reactivity profile continue to inspire new research directions and applications, solidifying its position as a key player in contemporary chemical innovation.
20443-38-3 (5-Chloro-2-chloromethyl-1H-benzoimidazole) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)